[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[india-drug] Re:Pharmacoeconomics/cost-effectiveness evidence(2)

From: "usha gupta" <usha_gupta2@yahoo.com>
Date: Mon, 29 Nov 2004 08:41:41 -0800 (PST)

Dear Vijay,

Several states in India are now procuring the medicines based on Essential Medicines List (EML) for Public Health Care System. Delhi state is one such example. While selecting such medicines to be included in the EML, cost effective evidence is one of the most important criteria considered.

Best wishes,
Dr Usha Gupta
Prof & Head Department of Pharmacology, Maulana Azad Medical College, New Delhi & Chairperson of Committtee For Selection Of Essential Medicines, Govt. Of NCT of Delhi

References:
- [india-drug] Pharmacoeconomics/cost-effectiveness evidence
  - From: Vijay Joish

Prev by Date: [india-drug] Pharmacoeconomics/cost-effectiveness evidence
Next by Date: [india-drug] Re: Generic drugs(3)
Previous by thread: [india-drug] Pharmacoeconomics/cost-effectiveness evidence
Next by thread: [india-drug] Sufactants for newborns in India
Index(es):
- Date
- Thread